Astle Christopher insider trades
Astle Christopher has filed 5 Form 4s with the SEC that we hold, for Zymeworks Inc. (ZYME) (SVP & Chief Financial Officer) and ZYME (SVP & Chief Financial Officer). Across all of them we count 0 purchases worth $0 and 4 sales worth $78.1K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 4,563 shares of Zymeworks Inc. worth $48.6K, dated 2024-01-05. The first filing on our record is dated 2022-03-11 and the latest 2024-01-08.
Zymeworks Inc. (ZYME)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-12-12 | S, sale reported on Form 4 | 887 | $5.3K | 2022-12-23 |
| 2023-12-11 | S, sale reported on Form 4 | 886 | $8.1K | 2023-12-11 |
| 2024-01-05 | S, sale reported on Form 4 | 4,563 | $48.6K | 2024-01-08 |
| 2024-01-08 | S, sale reported on Form 4 | 1,431 | $16.1K | 2024-01-08 |
ZYME (ZYME)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1915257) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms